Greek Registry of Myelofibrosis: Baseline Characteristics and Therapeutic Strategy
Damianos Sotiropoulos(G. Papanikolaou General Hospital), Constantinos Tsatalas(Democritus University of Thrace), Emmanouil Papadakis(Senologic Hellenic Society), Argiris Symeonidis(University of Patras), Nora‐Athina Viniou, Panayiotis Panayiotidis(National and Kapodistrian University of Athens), Maria Dimou(National and Kapodistrian University of Athens), Aggeliki Vourtsi(Senologic Hellenic Society), Maria Pagoni(National and Kapodistrian University of Athens), Theodoros Iliakis(Senologic Hellenic Society), Maria Kotsopoulou(Senologic Hellenic Society), Konstantinos Gkirkas(Senologic Hellenic Society), Evangelia Tzouvara(Senologic Hellenic Society), Anastasia Marvaki(Senologic Hellenic Society), Αchilles Anagnostopoulos(G. Papanikolaou General Hospital), Theodoros Marinakis(Senologic Hellenic Society), Panagiotis Zikos(Agios Andreas Hospital), Alexandra Kouraklis(Senologic Hellenic Society), Vassilios K Papadopoulos(Senologic Hellenic Society), Dimitrios Kokkinidis(Senologic Hellenic Society), Efthymia Vlachaki(Senologic Hellenic Society), Panagiotis Tsirigotis, Nikolaos Anagnostopoulos(Evangelismos Hospital)
Cited by 0
Related Papers
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia
|New England Journal of Medicine|2020|320
Primary Treatment of Waldenström Macroglobulinemia With Dexamethasone, Rituximab, and Cyclophosphamide
|Journal of Clinical Oncology|2007|279
Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases
|Blood|2011|178
Primary gastrointestinal non-Hodgkin's lymphoma: A clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG)
|Leukemia & lymphoma/Leukemia and lymphoma|2006|160